Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Neutralization of SARS-CoV-2 Variants B.1.429 and B.1.351New England Journal of Medicine, 2021-06, Vol.384 (24), p.2352-2354 [Peer Reviewed Journal]Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;2021. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;Copyright © 2021 Massachusetts Medical Society. All rights reserved. 2021 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMc2103740 ;PMID: 33826819Digital Resources/Online E-Resources |
|
2 |
Material Type: Article
|
A Bivalent Omicron-Containing Booster Vaccine against Covid-19The New England journal of medicine, 2022-10, Vol.387 (14), p.1279-1291 [Peer Reviewed Journal]Copyright © 2022 Massachusetts Medical Society. All rights reserved. ;COPYRIGHT 2022 Massachusetts Medical Society ;Copyright © 2022 Massachusetts Medical Society. All rights reserved. 2022 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2208343 ;PMID: 36112399Full text available |
|
3 |
Material Type: Article
|
SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral spike vaccinesCell host & microbe, 2021-04, Vol.29 (4), p.529-539.e3 [Peer Reviewed Journal]2021 Elsevier Inc. ;Copyright © 2021 Elsevier Inc. All rights reserved. ;COPYRIGHT 2021 Elsevier B.V. ;2021 Elsevier Inc. 2021 Elsevier Inc. ;ISSN: 1931-3128 ;EISSN: 1934-6069 ;DOI: 10.1016/j.chom.2021.03.002 ;PMID: 33705729Full text available |
|
4 |
Material Type: Article
|
SnapShot: SARS-CoV-2 antibodiesCell host & microbe, 2021-07, Vol.29 (7), p.1162-1162.e1 [Peer Reviewed Journal]2021 Elsevier Inc. ;2021 Elsevier Inc. 2021 Elsevier Inc. ;ISSN: 1931-3128 ;EISSN: 1934-6069 ;DOI: 10.1016/j.chom.2021.06.005 ;PMID: 34265246Full text available |
|
5 |
Material Type: Article
|
D614G Spike Mutation Increases SARS CoV-2 Susceptibility to NeutralizationCell Host & Microbe, 2021-01, Vol.29 (1), p.23-31.e4 [Peer Reviewed Journal]2020 ;Copyright © 2020. Published by Elsevier Inc. ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2020 Published by Elsevier Inc. 2020 ;ISSN: 1931-3128 ;EISSN: 1934-6069 ;DOI: 10.1016/j.chom.2020.11.012 ;PMID: 33306985Digital Resources/Online E-Resources |
|
6 |
Material Type: Article
|
Potential of conventional & bispecific broadly neutralizing antibodies for prevention of HIV-1 subtype A, C & D infectionsPLoS pathogens, 2018-03, Vol.14 (3), p.e1006860-e1006860 [Peer Reviewed Journal]COPYRIGHT 2018 Public Library of Science ;COPYRIGHT 2018 Public Library of Science ;2018 Public Library of Science. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited: Wagh K, Seaman MS, Zingg M, Fitzsimons T, Barouch DH, Burton DR, et al. (2018) Potential of conventional & bispecific broadly neutralizing antibodies for prevention of HIV-1 subtype A, C & D infections. PLoS Pathog 14(3): e1006860. https://doi.org/10.1371/journal.ppat.1006860 ;2018 Public Library of Science. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited: Wagh K, Seaman MS, Zingg M, Fitzsimons T, Barouch DH, Burton DR, et al. (2018) Potential of conventional & bispecific broadly neutralizing antibodies for prevention of HIV-1 subtype A, C & D infections. PLoS Pathog 14(3): e1006860. https://doi.org/10.1371/journal.ppat.1006860 ;ISSN: 1553-7374 ;ISSN: 1553-7366 ;EISSN: 1553-7374 ;DOI: 10.1371/journal.ppat.1006860 ;PMID: 29505593Full text available |
|
7 |
Material Type: Article
|
Optimal Combinations of Broadly Neutralizing Antibodies for Prevention and Treatment of HIV-1 Clade C InfectionPLoS pathogens, 2016-03, Vol.12 (3), p.e1005520-e1005520 [Peer Reviewed Journal]COPYRIGHT 2016 Public Library of Science ;COPYRIGHT 2016 Public Library of Science ;2016 Public Library of Science. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited: Wagh K, Bhattacharya T, Williamson C, Robles A, Bayne M, Garrity J, et al. (2016) Optimal Combinations of Broadly Neutralizing Antibodies for Prevention and Treatment of HIV-1 Clade C Infection. PLoS Pathog 12(3): e1005520. doi:10.1371/journal.ppat.1005520 ;2016 Public Library of Science. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited: Wagh K, Bhattacharya T, Williamson C, Robles A, Bayne M, Garrity J, et al. (2016) Optimal Combinations of Broadly Neutralizing Antibodies for Prevention and Treatment of HIV-1 Clade C Infection. PLoS Pathog 12(3): e1005520. doi:10.1371/journal.ppat.1005520 ;ISSN: 1553-7374 ;ISSN: 1553-7366 ;EISSN: 1553-7374 ;DOI: 10.1371/journal.ppat.1005520 ;PMID: 27028935Full text available |
|
8 |
Material Type: Article
|
Safety and immunogenicity of SARS-CoV-2 variant mRNA vaccine boosters in healthy adults: an interim analysisNature medicine, 2021-11, Vol.27 (11), p.2025-2031 [Peer Reviewed Journal]2021. The Author(s). ;COPYRIGHT 2021 Nature Publishing Group ;The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 1078-8956 ;EISSN: 1546-170X ;DOI: 10.1038/s41591-021-01527-y ;PMID: 34526698Full text available |
|
9 |
Material Type: Article
|
Structural diversity of the SARS-CoV-2 Omicron spikeMolecular cell, 2022-06, Vol.82 (11), p.2050-2068.e6 [Peer Reviewed Journal]2022 Elsevier Inc. ;Copyright © 2022 Elsevier Inc. All rights reserved. ;2022 Elsevier Inc. 2022 Elsevier Inc. ;ISSN: 1097-2765 ;EISSN: 1097-4164 ;DOI: 10.1016/j.molcel.2022.03.028 ;PMID: 35447081Full text available |
|
10 |
Material Type: Article
|
Bispecific Antibodies Against HIVCell, 2016-06, Vol.165 (7), p.1563-1564 [Peer Reviewed Journal]2016 Elsevier Inc. ;Copyright © 2016 Elsevier Inc. All rights reserved. ;ISSN: 0092-8674 ;EISSN: 1097-4172 ;DOI: 10.1016/j.cell.2016.06.004 ;PMID: 27315470Full text available |
|
11 |
Material Type: Article
|
Sequential and Simultaneous Immunization of Rabbits with HIV-1 Envelope Glycoprotein SOSIP.664 Trimers from Clades A, B and CPLoS pathogens, 2016-09, Vol.12 (9), p.e1005864-e1005864 [Peer Reviewed Journal]COPYRIGHT 2016 Public Library of Science ;COPYRIGHT 2016 Public Library of Science ;2016 Public Library of Science. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited: Klasse PJ, LaBranche CC, Ketas TJ, Ozorowski G, Cupo A, Pugach P, et al. (2016) Sequential and Simultaneous Immunization of Rabbits with HIV-1 Envelope Glycoprotein SOSIP.664 Trimers from Clades A, B and C. PLoS Pathog 12(9): e1005864. doi:10.1371/journal.ppat.1005864 ;2016 Klasse et al 2016 Klasse et al ;2016 Public Library of Science. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited: Klasse PJ, LaBranche CC, Ketas TJ, Ozorowski G, Cupo A, Pugach P, et al. (2016) Sequential and Simultaneous Immunization of Rabbits with HIV-1 Envelope Glycoprotein SOSIP.664 Trimers from Clades A, B and C. PLoS Pathog 12(9): e1005864. doi:10.1371/journal.ppat.1005864 ;ISSN: 1553-7374 ;ISSN: 1553-7366 ;EISSN: 1553-7374 ;DOI: 10.1371/journal.ppat.1005864 ;PMID: 27627672Full text available |
|
12 |
Material Type: Article
|
The SARS-CoV-2 Spike variant D614G favors an open conformational stateScience advances, 2021-04, Vol.7 (16) [Peer Reviewed Journal]Copyright © 2021 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution NonCommercial License 4.0 (CC BY-NC). ;Copyright © 2021 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution NonCommercial License 4.0 (CC BY-NC). 2021 The Authors ;ISSN: 2375-2548 ;EISSN: 2375-2548 ;DOI: 10.1126/sciadv.abf3671 ;PMID: 33863729Full text available |
|
13 |
Material Type: Article
|
Evaluation of mRNA-1273 Covid-19 Vaccine in Children 6 to 11 Years of AgeNew England Journal of Medicine, 2022-05, Vol.386 (21), p.2011-2023 [Peer Reviewed Journal]Copyright © 2022 Massachusetts Medical Society. All rights reserved. ;Copyright © 2022 Massachusetts Medical Society. ;COPYRIGHT 2022 Massachusetts Medical Society ;2022. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;Copyright © 2022 Massachusetts Medical Society. All rights reserved. 2022 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2203315 ;PMID: 35544369Digital Resources/Online E-Resources |
|
14 |
Material Type: Article
|
Towards a population-based threshold of protection for COVID-19 vaccinesVaccine, 2022-01, Vol.40 (2), p.306-315 [Peer Reviewed Journal]2021 The Author(s) ;Copyright © 2021 The Author(s). Published by Elsevier Ltd.. All rights reserved. ;2021. The Author(s) ;2021 The Author(s) 2021 ;ISSN: 0264-410X ;EISSN: 1873-2518 ;DOI: 10.1016/j.vaccine.2021.12.006 ;PMID: 34933765Full text available |
|
15 |
Material Type: Article
|
Epitopes for neutralizing antibodies induced by HIV-1 envelope glycoprotein BG505 SOSIP trimers in rabbits and macaquesPLoS pathogens, 2018-02, Vol.14 (2), p.e1006913-e1006913 [Peer Reviewed Journal]COPYRIGHT 2018 Public Library of Science ;COPYRIGHT 2018 Public Library of Science ;2018 Public Library of Science. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited: Klasse PJ, Ketas TJ, Cottrell CA, Ozorowski G, Debnath G, Camara D, et al. (2018) Epitopes for neutralizing antibodies induced by HIV-1 envelope glycoprotein BG505 SOSIP trimers in rabbits and macaques. PLoS Pathog 14(2): e1006913. https://doi.org/10.1371/journal.ppat.1006913 ;2018 Klasse et al 2018 Klasse et al ;2018 Public Library of Science. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited: Klasse PJ, Ketas TJ, Cottrell CA, Ozorowski G, Debnath G, Camara D, et al. (2018) Epitopes for neutralizing antibodies induced by HIV-1 envelope glycoprotein BG505 SOSIP trimers in rabbits and macaques. PLoS Pathog 14(2): e1006913. https://doi.org/10.1371/journal.ppat.1006913 ;ISSN: 1553-7374 ;ISSN: 1553-7366 ;EISSN: 1553-7374 ;DOI: 10.1371/journal.ppat.1006913 ;PMID: 29474444Full text available |
|
16 |
Material Type: Article
|
Vaccine-induced plasma IgA specific for the C1 region of the HIV-1 envelope blocks binding and effector function of IgGProceedings of the National Academy of Sciences - PNAS, 2013-05, Vol.110 (22), p.9019-9024 [Peer Reviewed Journal]copyright © 1993-2008 National Academy of Sciences of the United States of America ;Copyright National Academy of Sciences May 28, 2013 ;ISSN: 0027-8424 ;EISSN: 1091-6490 ;DOI: 10.1073/pnas.1301456110 ;PMID: 23661056Full text available |
|
17 |
Material Type: Article
|
Global Panel of HIV-1 Env Reference Strains for Standardized Assessments of Vaccine-Elicited Neutralizing AntibodiesJournal of Virology, 2014-03, Vol.88 (5), p.2489-2507 [Peer Reviewed Journal]Copyright © 2014, American Society for Microbiology. All Rights Reserved. 2014 American Society for Microbiology ;ISSN: 0022-538X ;EISSN: 1098-5514 ;DOI: 10.1128/JVI.02853-13 ;PMID: 24352443Full text available |
|
18 |
Material Type: Article
|
Vaccine-induced IgG antibodies to V1V2 regions of multiple HIV-1 subtypes correlate with decreased risk of HIV-1 infectionPloS one, 2014-02, Vol.9 (2), p.e87572-e87572 [Peer Reviewed Journal]COPYRIGHT 2014 Public Library of Science ;COPYRIGHT 2014 Public Library of Science ;2014. This is an open-access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2014 ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0087572 ;PMID: 24504509Full text available |
|
19 |
Material Type: Article
|
Enhanced immunity after Ad26.COV2.S vaccine breakthrough infectionCell reports. Medicine, 2022-03, Vol.3 (3), p.100579, Article 100579 [Peer Reviewed Journal]2022 The Author(s) ;2022 The Author(s). ;2022 The Author(s) 2022 ;ISSN: 2666-3791 ;EISSN: 2666-3791 ;DOI: 10.1016/j.xcrm.2022.100579 ;PMID: 35474738Full text available |
|
20 |
Material Type: Article
|
Evidence that Ecotropic Murine Leukemia Virus Contamination in TZM-bl Cells Does Not Affect the Outcome of Neutralizing Antibody Assays with Human Immunodeficiency Virus Type 1Journal of Virology, 2009-08, Vol.83 (16), p.8289-8292 [Peer Reviewed Journal]2009 INIST-CNRS ;Copyright © 2009, American Society for Microbiology ;ISSN: 0022-538X ;EISSN: 1098-5514 ;DOI: 10.1128/JVI.00709-09 ;PMID: 19474095Full text available |